News | February 03, 2014

Researcher Finds Significant Cardiac Treatment Imbalance Nationally

February 3, 2014 — Percutaneous coronary intervention (PCI) centers are unequal relative to population and heart attack prevalence across the United States, according to a study in the Journal of the American Heart Association. A multi-center team led by James Langabeer II, Ph.D., The University of Texas Health Science Center at Houston, conducted the study
Langabeer and co-lead author Timothy Henry, M.D., Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, found that people who live in urban areas have access to more PCI centers than necessary. Those who live in some rural areas are unable to access a PCI center within 60 minutes, the recommended time to receive treatment after the onset of heart attack symptoms.
Researchers examined the distribution of PCI centers in each state and compared that to population density and heart attack prevalence. The number of PCI centers has grown 21 percent nationwide in the last eight years, with 39 percent of all hospitals having interventional cardiology capabilities. While PCI centers continue to grow, heart attacks are decreasing. Langabeer’s discovery unveils an unequal geographic distribution of PCI capacity for treating heart attack patients.
Some western states, such as Nevada, had higher than median disease prevalence rates, yet have only an average number of PCI centers for its population. Locations in the south central and north central region, such as Alabama and Montana, had significantly higher relative PCI facilities compared to some of the states with even higher disease rates.
“There is a growing trend nationally for hospitals to all become PCI capable, for a variety of reasons. As long as the capacity is aligned with the need, this is positive. However, in this research, we found significant disparity geographically when we normalized capacity by population density” Langabeer said. “These imbalances are creating problems on a national scale.”
The study is called "Growth in Percutaneous Coronary Intervention Capacity Relative to Population and Disease Prevalence." Co-authors are from the American Heart Association, Boston University School of Medicine, Duke University Medical Center, The Christ Hospital Heart and Vascular Center and UT Southwestern Medical Center.
For more information:

Related Content

Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Overlay Init